BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Arthur Klausner will sit on a panel at the 11th Annual Drug Delivery Technologies and Deal Making Conference, sponsored by SRI
News | 09. 26. 2006
